Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Serina Therapeutics (SER) stock jumped 39% after-hours on news of a $30M private placement and Greg Bailey's appointment as ...

Serina Therapeutics Inc. (NYSEAMERICAN: SER) shares jumped 34.93% to $3.67 in after-hours trading on Wednesday after Food and Drug Administration cleared its Investigational New Drug application for ...

We conducted a phase 3, double-blind, randomized, placebo-controlled trial in which patients who had had three or more episodes of C. difficile infection (inclusive of the qualifying acute episode) ...

Seres Therapeutics’s VOWST divestiture injected cash, retired debt, and refocused the company as a clinical‑stage microbiome specialist. Their current lead candidate is SER‑155, which seems to reduce ...

REDWOOD CITY, Calif. & NEW YORK--(BUSINESS WIRE)--SER Capital Partners (SER), a private investment firm dedicated to sustainability, today announced the final closing of its SER Capital Partners I, LP ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...